Validation of Simplified Renal Dosimetry Protocols for 177Lu-DOTATATE Therapy Using the IDAC-dose Software
Open Access
- 4 June 2026
- journal article
- Published by Galenos Yayinevi in Molecular Imaging and Radionuclide Therapy
- Vol. 35 (2) , 92-104
Abstract
Validation of Simplified Renal Dosimetry Protocols for 177Lu-DOTATATE Therapy Using the IDAC-dose Software - Molecular Imaging and Radionuclide TherapyKeywords
All Related Versions
This publication has 34 references indexed in Scilit:
- Uncertainty estimation for dosimetry in radiation oncologyPhysics and Imaging in Radiation Oncology, 2025
- A comparison of simplified protocols of personalized dosimetry in NEN patients treated by radioligand therapy (RLT) with [177Lu]Lu-DOTATATE to favor its use in clinical practiceEuropean Journal of Nuclear Medicine and Molecular Imaging, 2023
- Overview of the 2022 WHO Classification of Neuroendocrine NeoplasmsEndocrine Pathology, 2022
- 177Lu-Dotatate plus long-acting octreotide versus high‑dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trialThe Lancet Oncology, 2021
- Comparison of commercial dosimetric software platforms in patients treated with 177Lu‐DOTATATE for peptide receptor radionuclide therapyMedical Physics, 2020
- A dosimetry procedure for organs-at-risk in 177Lu peptide receptor radionuclide therapy of patients with neuroendocrine tumoursPhysica Medica, 2018
- Technical Note: Single time point dose estimate for exponential clearanceMedical Physics, 2018
- Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factorsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2008
- Receptor radionuclide therapy with 90Y-[DOTA]0-Tyr3-octreotide (90Y-DOTATOC) in neuroendocrine tumoursEuropean Journal of Nuclear Medicine and Molecular Imaging, 2004
- A new cause of renal thrombotic microangiopathy: Yttrium 90-DOTATOC internal radiotherapyAmerican Journal of Kidney Diseases, 2001